Pharma firms need to get hip to HIPAA, particularly concerning CROs and PBMs, attorney says.(HIPAA): An article from: Bioresearch Monitoring Alert
Pharma firms need to get hip to HIPAA, particularly concerning CROs and PBMs, attorney says.(HIPAA): An article from: Bioresearch Monitoring Alert
This digital document is an article from Bioresearch Monitoring Alert, published by Thomson Gale on July 1, 2005. The length of the article is 646 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Pharma firms need to get hip to HIPAA, particularly concerning CROs and PBMs, attorney says.(HIPAA)
Author: Diane West
Publication: Bioresearch Monitoring Alert (Newsletter)
Date: July 1, 2005
Publisher: Thomson Gale
Volume: 5 Issue: 7 Page: 2
Distributed by Thomson Gale
Pharma firms need to get hip to HIPAA, particularly concerning CROs and PBMs, attorney says.(HIPAA): An article from: Bioresearch Monitoring Alert
About the Author
